Child anxiety treatment in the context of COVID-19

Child Anxiety Treatment in the context of COVID-19 (Co-CAT): Enabling Child and Adolescent Mental Health Services (CAMHS) to provide efficient remote treatment for child anxiety problems

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12890382

Enrollment

560

Registered

2020-10-23

Start date

2020-11-02

Completion date

Unknown

Last updated

2024-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety problems in children aged 5-12 Mental and Behavioural Disorders

Interventions

Intervention(s) Online psychological intervention for child anxiety with therapist support (OSI+therapist support). OSI is an online platform for sharing content and record keeping as part of a brief

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Child inclusion criteria: 1. Aged 5-12 years at intake 2. Primary problem is anxiety 3. Willing and able to assent Parent/Carer inclusion criteria: 1. Has sufficient English language to complete measures/ access interventions 2. Family has access to the internet 3. Is willing and able to provide consent

Exclusion criteria

Exclusion criteria: Child exclusion criteria: 1. The child has co-morbid conditions that are likely to interfere with treatment delivery, (established autism spectrum condition/ learning disability, suicidal intent/ recurrent or potentially life-limiting self-harm) 2. The child is identified by social services due to child protection concerns Parent/Carer exclusion criteria: 1. The parent has a significant intellectual impairment or severe mental health problem that is likely to interfere with treatment delivery 2. The parents are unable to access or understand the written English language materials necessary for the interventions

Design outcomes

Primary

Measure	Time frame
Child Anxiety is measured using a parent self-report questionnaire (The Child Anxiety Impact Scale-parent report, CAIS-P) at baseline, 14 weeks, and 26 weeks.	—

Secondary

Measure	Time frame
Secondary Clinical Outcomes: 1. Child reported anxiety is measured using a child self-report questionnaire (CAIS-C, RCADS-C) at baseline, 14 weeks, and 26 weeks 2. Parent report on child’s anxiety symptoms is measured using a self-report questionnaire (RCADS-P, SCAS-8P) 3. Parent report on overall functioning is measured using a self-report questionnaire (ORS) at baseline, 14 weeks, and 26 weeks 4. Parent report COVID-19 specific worries is measured using a self-report questionnaire (PAS) at baseline, 14 weeks, and 26 weeks 5. Parent report on common comorbid emotional and behavioural problems is measured using a self-report questionnaire (SDQ-P) at baseline, 14 weeks, and 26 weeks Economic Outcomes: 6. Parent report on their quality of life is measured using a self-report questionnaire (EQ-5D-5L, parent-self report) at baseline, 14 weeks, and 26 weeks 7. Parent report on their child’s quality of life is measured using a self-report questionnaire (CHU-9D proxy version) at baseline, 14 weeks, and 26 weeks 8. Parent report on their use of services is measured using a self-report questionnaire (CSRI) at baseline, 14 weeks, and 26 weeks 9. Time spent on treatment delivery is measured by a therapist completed log of time spent on treatment delivery for each participant Exploratory Outcomes: 10. Child outcomes will be monitored during treatment for the OSI+therapist support arm using parent self-report questionnaires built into the system (OSI RCADS-P CAIS-P SCAS-8P ORS SRS GBOs), collected at the beginning of each module (module 1-7)	—

Measure

Time frame

Secondary Clinical Outcomes: 1. Child reported anxiety is measured using a child self-report questionnaire (CAIS-C, RCADS-C) at baseline, 14 weeks, and 26 weeks 2. Parent report on child’s anxiety symptoms is measured using a self-report questionnaire (RCADS-P, SCAS-8P) 3. Parent report on overall functioning is measured using a self-report questionnaire (ORS) at baseline, 14 weeks, and 26 weeks 4. Parent report COVID-19 specific worries is measured using a self-report questionnaire (PAS) at baseline, 14 weeks, and 26 weeks 5. Parent report on common comorbid emotional and behavioural problems is measured using a self-report questionnaire (SDQ-P) at baseline, 14 weeks, and 26 weeks Economic Outcomes: 6. Parent report on their quality of life is measured using a self-report questionnaire (EQ-5D-5L, parent-self report) at baseline, 14 weeks, and 26 weeks 7. Parent report on their child’s quality of life is measured using a self-report questionnaire (CHU-9D proxy version) at baseline, 14 weeks, and 26 weeks 8. Parent report on their use of services is measured using a self-report questionnaire (CSRI) at baseline, 14 weeks, and 26 weeks 9. Time spent on treatment delivery is measured by a therapist completed log of time spent on treatment delivery for each participant Exploratory Outcomes: 10. Child outcomes will be monitored during treatment for the OSI+therapist support arm using parent self-report questionnaires built into the system (OSI RCADS-P CAIS-P SCAS-8P ORS SRS GBOs), collected at the beginning of each module (module 1-7)

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026